Copyright: ©Author(s) 2026.
World J Psychiatry. Nov 19, 2026; 16(11): 122026
Published online Nov 19, 2026. doi: 10.5498/wjp.122026
Published online Nov 19, 2026. doi: 10.5498/wjp.122026
Table 1 Baseline characteristics of the study participants
| Characteristic | Treatment group (n = 64) | Control group (n = 64) | P value |
| Age (years) | 65.3 ± 10.8 | 66.1 ± 11.2 | 0.685 |
| Sex (female, %) | 52.5 | 48.4 | 0.638 |
| Education (college or higher, %) | 34.4 | 32.3 | 0.799 |
| NIHSS score at admission | 7.2 ± 2.1 | 7.1 ± 2.0 | 0.774 |
| History of hypertension (%) | 68.8 | 65.6 | 0.683 |
| History of diabetes (%) | 28.1 | 26.6 | 0.837 |
| Smoking history (%) | 32.8 | 29.7 | 0.688 |
| Baseline HAMD-17 score | 22.8 ± 4.5 | 22.3 ± 4.2 | 0.516 |
| Baseline HAMA score | 18.6 ± 4.2 | 18.1 ± 3.9 | 0.478 |
| Baseline MoCA score | 22.5 ± 3.2 | 22.3 ± 3.1 | 0.715 |
- Citation: Song HY, Yang Y, Sun XY, Zhang MJ, Wang SG. Serum proprotein convertase subtilisin/kexin type 9 levels correlate with depression severity in post-stroke patients. World J Psychiatry 2026; 16(11): 122026
- URL: https://www.wjgnet.com/2220-3206/full/v16/i11/122026.htm
- DOI: https://dx.doi.org/10.5498/wjp.122026